Keywords: Pfizer, Financial results, Second-quarter 2012

Pfizer's 2nd-qtr net income leaps 25% despite Lipitor generics

Article | 01 August 2012

US drugs behemoth Pfizer (NYSE: PFE) reported second quarter 2012 financial results, showing that revenue declined 9% to $15.1 billion, impacted by generic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Pfizer

Go to company listing